Jiangsu Recbio Technology Co., Ltd. Profile Avatar - Palmy Investing

Jiangsu Recbio Technology Co., Ltd.

Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer and genital…
Biotechnology
CN, Taizhou [HQ]
2179.HK/Financial Reporting

Income Statements

Profit & Loss · 5 Statements · From 2023 to 2019
Configuration
In Million CNY. Margins, Growth Rates In %
Metric 2019 2020 2021 2022 2023
Revenue
- - 1.00 6.00 5.00 30.00
EPS
-0.43 -0.44 -1.57 -1.52 -1.19
Profit
- - 1.00 6.00 5.00 22.00
Pre Tax
-138.00 -179.00 -657.00 -735.00 -572.00
ETR
-47.38 -17.69 -6.86 2.28 0.08
Net
-203.00 -211.00 -702.00 -719.00 -571.00
EBITDA
-68.00 -134.00 -589.00 -695.00 -569.00
Operating Income
-72.00 -147.00 -612.00 -735.00 -617.00
Interest Income
2.00 2.00 10.00 23.00 32.00
Loss
-74.00 -147.00 -613.00 -875.00 -634.00
Cost of Revenue
- - - - - - - - -8.00
Operating Expenses
-74.00 -147.00 -613.00 -875.00 -626.00
Depreciation and Amortization
-4.00 -12.00 -22.00 -40.00 -63.00
Interest Expenses
-76.00 -37.00 -56.00 -3.00 - -
Other Expenses
-65.00 -31.00 -45.00 - - -45.00
WA Shares Outstanding
479.00 479.00 448.00 474.00 480.00